196 related articles for article (PubMed ID: 12568485)
1. Epidemiological studies in mucus hypersecretion.
Vestbo J
Novartis Found Symp; 2002; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
[TBL] [Abstract][Full Text] [Related]
2. Current and future therapies for airway mucus hypersecretion.
Barnes PJ
Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
4. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
Vestbo J; Prescott E; Lange P
Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of bronchial hypersecretion: recent studies.
Pride NB
Eur J Respir Dis Suppl; 1987; 153():13-8. PubMed ID: 3322856
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
7. Mucin-producing elements and inflammatory cells.
Jeffery P; Zhu J
Novartis Found Symp; 2002; 248():51-68; discussion 68-75, 277-82. PubMed ID: 12568488
[TBL] [Abstract][Full Text] [Related]
8. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
9. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
10. Chronic mucus hypersecretion, exacerbations and natural history of COPD.
Vestbo J
Exp Lung Res; 2005 Sep; 31 Suppl 1():63-5. PubMed ID: 16395861
[No Abstract] [Full Text] [Related]
11. Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH.
Dijkstra AE; de Jong K; Boezen HM; Kromhout H; Vermeulen R; Groen HJ; Postma DS; Vonk JM
Occup Environ Med; 2014 May; 71(5):346-52. PubMed ID: 24642640
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease.
Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
Acta Pharmacol Sin; 2007 Aug; 28(8):1166-74. PubMed ID: 17640479
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of human calcium-activated chloride channel 1 is correlated with mucus overproduction in the airways of Chinese patients with chronic obstructive pulmonary disease.
Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
Chin Med J (Engl); 2007 Jun; 120(12):1051-7. PubMed ID: 17637221
[TBL] [Abstract][Full Text] [Related]
14. Chronic mucus hypersecretion: a marker of asthma in young adults?
Ulrik CS; von Linstow ML; Nepper-Christensen S; Porsbjerg C; Backer V
Respir Med; 2005 Dec; 99(12):1576-82. PubMed ID: 16291078
[TBL] [Abstract][Full Text] [Related]
15. What predicts change in pulmonary function and quality of life in asthma or COPD?
Hesselink AE; van der Windt DA; Penninx BW; Wijnhoven HA; Twisk JW; Bouter LM; van Eijk JT
J Asthma; 2006 Sep; 43(7):513-9. PubMed ID: 16939991
[TBL] [Abstract][Full Text] [Related]
16. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer.
Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
Am Rev Respir Dis; 1990 Mar; 141(3):613-7. PubMed ID: 2310094
[TBL] [Abstract][Full Text] [Related]
17. Respiratory symptoms among residents of a heavy-industry province in China: prevalence and risk factors.
Wilson D; Takahashi K; Pan G; Chan CC; Zhang S; Feng Y; Hoshuyama T; Chuang KJ; Lin RT; Hwang JS
Respir Med; 2008 Nov; 102(11):1536-44. PubMed ID: 18684604
[TBL] [Abstract][Full Text] [Related]
18. The overlap syndrome of asthma and COPD: what are its features and how important is it?
Gibson PG; Simpson JL
Thorax; 2009 Aug; 64(8):728-35. PubMed ID: 19638566
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for hospital mortality in patients with chronic obstructive pulmonary diseases requiring invasive mechanical ventilation.
Liu H; Zhang TT; Ye J
Chin Med J (Engl); 2007 Feb; 120(4):287-93. PubMed ID: 17374279
[TBL] [Abstract][Full Text] [Related]
20. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
